{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T20:29:45Z","timestamp":1793046585389,"version":"4.5.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,4,19]],"date-time":"2013-04-19T00:00:00Z","timestamp":1366329600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1007\/s10549-013-2521-2","type":"journal-article","created":{"date-parts":[[2013,4,18]],"date-time":"2013-04-18T01:21:37Z","timestamp":1366248097000},"page":"227-235","source":"Crossref","is-referenced-by-count":58,"title":["Comorbidities and breast cancer survival: a report from the Shanghai Breast Cancer Survival Study"],"prefix":"10.1007","volume":"139","author":[{"given":"Sarah","family":"Nechuta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping-Ping","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao Ou","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,4,19]]},"reference":[{"key":"2521_CR1","unstructured":"Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM (2010) GLOBOCAN 2008 v1.2, Cancer Incidence and Mortality Worldwide. Lyon, France: International Agency for Research on Cancer. Available from: http:\/\/globocan.iarc.fr . Accessed 07 June 2012"},{"key":"2521_CR2","volume-title":"Breast cancer facts & figures\u00a02011\u20132012","author":"American Cancer Society","year":"2012","unstructured":"American Cancer Society (2012) Breast cancer facts & figures\u00a02011\u20132012. American Cancer Society, Atlanta"},{"key":"2521_CR3","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.phr.2004.04.005","volume":"119","author":"G Anderson","year":"2004","unstructured":"Anderson G, Horvath J (2004) The growing burden of chronic disease in America. Public Health Rep 119:263\u2013270","journal-title":"Public Health Rep"},{"key":"2521_CR4","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s11764-009-0084-3","volume":"3","author":"LC Harlan","year":"2009","unstructured":"Harlan LC, Klabunde CN, Ambs AH, Gibson T, Bernstein L, McTiernan A, Meeske K, Baumgartner KB, Ballard-Barbash R (2009) Comorbidities, therapy, and newly diagnosed conditions for women with early stage breast cancer. J Cancer Surviv 3:89\u201398","journal-title":"J Cancer Surviv"},{"key":"2521_CR5","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1093\/jnci\/djr188","volume":"103","author":"JL Patnaik","year":"2011","unstructured":"Patnaik JL, Byers T, DiGuiseppi C, Denberg TD, Dabelea D (2011) The influence of comorbidities on overall survival among older women diagnosed with breast cancer. J Natl Cancer I 103:1101\u20131111","journal-title":"J Natl Cancer I"},{"key":"2521_CR6","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1158\/1055-9965.EPI-11-0459","volume":"20","author":"AJ Sheppard","year":"2011","unstructured":"Sheppard AJ, Chiarelli AM, Marrett LD, Nishri ED, Trudeau ME (2011) Stage at diagnosis and comorbidity influence breast cancer survival in first nations women in Ontario, Canada. Cancer Epidem Biomar 20:2160\u20132167","journal-title":"Cancer Epidem Biomar"},{"key":"2521_CR7","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1007\/s10549-011-1819-1","volume":"131","author":"LH Land","year":"2012","unstructured":"Land LH, Dalton SO, Jensen MB, Ewertz M (2012) Impact of comorbidity on mortality: a cohort study of 62,591 Danish women diagnosed with early breast cancer, 1990\u20132008. Breast Cancer Res Treat 131:1013\u20131020","journal-title":"Breast Cancer Res Treat"},{"key":"2521_CR8","doi-asserted-by":"crossref","first-page":"104","DOI":"10.7326\/0003-4819-120-2-199401150-00002","volume":"120","author":"WA Satariano","year":"1994","unstructured":"Satariano WA, Ragland DR (1994) The effect of comorbidity on 3-year survival of women with primary breast-cancer. Ann Intern Med 120:104\u2013110","journal-title":"Ann Intern Med"},{"key":"2521_CR9","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.ejca.2004.12.025","volume":"41","author":"WJ Louwman","year":"2005","unstructured":"Louwman WJ, Janssen-Heijnen ML, Houterman S, Voogd AC, van der Sangen MJ, Nieuwenhuijzen GA, Coebergh JW (2005) Less extensive treatment and inferior prognosis for breast cancer patient with comorbidity: a population-based study. Eur J Cancer 41:779\u2013785","journal-title":"Eur J Cancer"},{"key":"2521_CR10","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1007\/s10549-010-0732-3","volume":"122","author":"RE Patterson","year":"2010","unstructured":"Patterson RE, Flatt SW, Saquib N, Rock CL, Caan BJ, Parker BA, Laughlin GA, Erickson K, Thomson CA, Bardwell WA et al (2010) Medical comorbidities predict mortality in women with a history of early stage breast cancer. Breast Cancer Res Treat 122:859\u2013865","journal-title":"Breast Cancer Res Treat"},{"key":"2521_CR11","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.critrevonc.2011.03.001","volume":"81","author":"LH Land","year":"2012","unstructured":"Land LH, Dalton SO, Jorgensen TL, Ewertz M (2012) Comorbidity and survival after early breast cancer. A review. Crit Rev Oncol Hematol 81:196\u2013205","journal-title":"Crit Rev Oncol Hematol"},{"key":"2521_CR12","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S1047-2797(96)00096-8","volume":"6","author":"DW West","year":"1996","unstructured":"West DW, Satariano WA, Ragland DR, Hiatt RA (1996) Comorbidity and breast cancer survival: a comparison between black and white women. Ann Epidemiol 6:413\u2013419","journal-title":"Ann Epidemiol"},{"key":"2521_CR13","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1007\/s00432-004-0594-3","volume":"130","author":"G Nagel","year":"2004","unstructured":"Nagel G, Wedding U, Rohrig B, Katenkamp D (2004) The impact of comorbidity on the survival of postmenopausal women with breast cancer. J Cancer Res Clin Oncol 130:664\u2013670","journal-title":"J Cancer Res Clin Oncol"},{"key":"2521_CR14","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1038\/sj.bjc.6601844","volume":"90","author":"S Houterman","year":"2004","unstructured":"Houterman S, Janssen-Heijnen MLG, Verheij CDGW, Louwman WJ, Vreugdenhil G, van der Sangen MJC, Coebergh JWW (2004) Comorbidity has negligible impact on treatment and complications but influences survival in breast cancer patients. Brit J Cancer 90:2332\u20132337","journal-title":"Brit J Cancer"},{"key":"2521_CR15","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/S0895-4356(03)00079-9","volume":"56","author":"G Maskarinec","year":"2003","unstructured":"Maskarinec G, Pagano IS, Yamashiro G, Issell BF (2003) Influences of ethnicity, treatment, and comorbidity on breast cancer survival in Hawaii. J Clin Epidemiol 56:678\u2013685","journal-title":"J Clin Epidemiol"},{"key":"2521_CR16","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1001\/jama.291.20.2441","volume":"291","author":"JF Piccirillo","year":"2004","unstructured":"Piccirillo JF, Tierney RM, Costas I, Grove L, Spitznagel EL Jr (2004) Prognostic importance of comorbidity in a hospital-based cancer registry. JAMA 291:2441\u20132447","journal-title":"JAMA"},{"key":"2521_CR17","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1038\/sj.bjc.6603717","volume":"96","author":"DP Cronin-Fenton","year":"2007","unstructured":"Cronin-Fenton DP, Norgaard M, Jacobsen J, Garne JP, Ewertz M, Lash TL, Sorensen HT (2007) Comorbidity and survival of Danish breast cancer patients from 1995 to 2005. Br J Cancer 96:1462\u20131468","journal-title":"Br J Cancer"},{"key":"2521_CR18","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1002\/ijc.22979","volume":"121","author":"SO Dalton","year":"2007","unstructured":"Dalton SO, Ross L, Duering M, Carlsen K, Mortensen PB, Lynch J, Johansen C (2007) Influence of socioeconomic factors on survival after breast cancer\u2014a nationwide cohort study of women diagnosed with breast cancer in Denmark 1983\u20131999. Int J Cancer 121:2524\u20132531","journal-title":"Int J Cancer"},{"key":"2521_CR19","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s10549-012-2176-4","volume":"135","author":"A Berglund","year":"2012","unstructured":"Berglund A, Wigertz A, Adolfsson J, Ahlgren J, Fornander T, Warnberg F, Lambe M (2012) Impact of comorbidity on management and mortality in women diagnosed with breast cancer. Breast Cancer Res Treat 135:281\u2013289","journal-title":"Breast Cancer Res Treat"},{"key":"2521_CR20","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1002\/ijc.24054","volume":"124","author":"D Braithwaite","year":"2009","unstructured":"Braithwaite D, Tammemagi CM, Moore DH, Ozanne EM, Hiatt RA, Belkora J, West DW, Satariano WA, Liebman M, Esserman L (2009) Hypertension is an independent predictor of survival disparity between African-American and white breast cancer patients. Int J Cancer 124:1213\u20131219","journal-title":"Int J Cancer"},{"key":"2521_CR21","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1093\/jnci\/djr239","volume":"103","author":"W McCaskill-Stevens","year":"2011","unstructured":"McCaskill-Stevens W, Abrams JS (2011) Comorbidities in the aging breast cancer population: are current assessments leading to improved outcomes? J Natl Cancer I 103:1072\u20131073","journal-title":"J Natl Cancer I"},{"key":"2521_CR22","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1001\/jama.285.7.885","volume":"285","author":"R Yancik","year":"2001","unstructured":"Yancik R, Wesley MN, Ries LAG, Havlik RJ, Edwards BK, Yates JW (2001) Effect of age and comorbidity in postmenopausal breast cancer patients aged 55\u00a0years and older. J Am Med Assoc 285:885\u2013892","journal-title":"J Am Med Assoc"},{"key":"2521_CR23","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1016\/j.ejca.2007.06.008","volume":"43","author":"ML Janssen-Heijnen","year":"2007","unstructured":"Janssen-Heijnen ML, Maas HA, Houterman S, Lemmens VE, Rutten HJ, Coebergh JW (2007) Comorbidity in older surgical cancer patients: influence on patient care and outcome. Eur J Cancer 43:2179\u20132193","journal-title":"Eur J Cancer"},{"issue":"3","key":"2521_CR24","doi-asserted-by":"crossref","first-page":"R64","DOI":"10.1186\/bcr2901","volume":"13","author":"JL Patnaik","year":"2011","unstructured":"Patnaik JL, Byers T, DiGuiseppi C, Dabelea D, Denberg TD (2011) Cardiovascular disease competes with breast cancer as the leading cause of death for older females diagnosed with breast cancer: a retrospective cohort study. Breast Cancer Res 13(3):R64","journal-title":"Breast Cancer Res"},{"key":"2521_CR25","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1001\/jama.2009.1783","volume":"302","author":"XO Shu","year":"2009","unstructured":"Shu XO, Zheng Y, Cai H, Gu K, Chen Z, Zheng W, Lu W (2009) Soy food intake and breast cancer survival. JAMA 302:2437\u20132443","journal-title":"JAMA"},{"key":"2521_CR26","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/1471-2288-11-72","volume":"11","author":"V Gupta","year":"2011","unstructured":"Gupta V, Gu K, Chen Z, Lu W, Shu XO, Zheng Y (2011) Concordance of self-reported and medical chart information on cancer diagnosis and treatment. BMC Med Res Methodol 11:72","journal-title":"BMC Med Res Methodol"},{"key":"2521_CR27","doi-asserted-by":"crossref","first-page":"S498","DOI":"10.1097\/00005768-200009001-00009","volume":"32","author":"BE Ainsworth","year":"2000","unstructured":"Ainsworth BE, Haskell WL, Whitt MC, Irwin ML, Swartz AM, Strath SJ, O\u2019Brien WL, Bassett DR Jr, Schmitz KH, Emplaincourt PO et al (2000) Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exerc 32:S498\u2013S504","journal-title":"Med Sci Sports Exerc"},{"key":"2521_CR28","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1093\/oxfordjournals.aje.a009034","volume":"145","author":"EL Korn","year":"1997","unstructured":"Korn EL, Graubard BI, Midthune D (1997) Time-to-event analysis of longitudinal follow-up of a survey: choice of the time-scale. Am J Epidemiol 145:72\u201380","journal-title":"Am J Epidemiol"},{"key":"2521_CR29","doi-asserted-by":"crossref","DOI":"10.1007\/0-387-29150-4","volume-title":"Survival analysis: a self-learning text","author":"D Kleinbaum","year":"2005","unstructured":"Kleinbaum D, Klien M (2005) Survival analysis: a self-learning text. Springer Science+Business Media, New York"},{"key":"2521_CR30","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1158\/1055-9965.EPI-11-1228","volume":"21","author":"D Braithwaite","year":"2012","unstructured":"Braithwaite D, Moore DH, Satariano WA, Kwan ML, Hiatt RA, Kroenke C, Caan BJ (2012) Prognostic impact of comorbidity among long-term breast cancer survivors: results from the LACE study. Cancer Epidemiol Biomarkers Prev 21:1115\u20131125","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2521_CR31","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s10549-011-1505-3","volume":"129","author":"PA Ganz","year":"2011","unstructured":"Ganz PA, Habel LA, Weltzien EK, Caan BJ, Cole SW (2011) Examining the influence of beta blockers and ACE inhibitors on the risk for breast cancer recurrence: results from the LACE cohort. Breast Cancer Res Treat 129:549\u2013556","journal-title":"Breast Cancer Res Treat"},{"key":"2521_CR32","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s10549-007-9654-0","volume":"109","author":"LL Lipscombe","year":"2008","unstructured":"Lipscombe LL, Goodwin PJ, Zinman B, McLaughlin JR, Hux JE (2008) The impact of diabetes on survival following breast cancer. Breast Cancer Res Treat 109:389\u2013395","journal-title":"Breast Cancer Res Treat"},{"key":"2521_CR33","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/S0140-6736(10)60826-4","volume":"376","author":"DL Scott","year":"2010","unstructured":"Scott DL, Wolfe F, Huizinga TW (2010) Rheumatoid arthritis. Lancet 376:1094\u20131108","journal-title":"Lancet"},{"key":"2521_CR34","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1186\/bcr3336","volume":"14","author":"MD Holmes","year":"2012","unstructured":"Holmes MD, Chen WY (2012) Hiding in plain view: the potential for commonly used drugs to reduce breast cancer mortality. Breast Cancer Res 14:216","journal-title":"Breast Cancer Res"},{"key":"2521_CR35","doi-asserted-by":"crossref","first-page":"628","DOI":"10.18632\/oncotarget.197","volume":"1","author":"DG Powe","year":"2010","unstructured":"Powe DG, Voss MJ, Zanker KS, Habashy HO, Green AR, Ellis IO, Entschladen F (2010) Beta-blocker drug therapy reduces secondary cancer formation in breast cancer and improves cancer specific survival. Oncotarget 1:628\u2013638","journal-title":"Oncotarget"},{"key":"2521_CR36","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1200\/JCO.2010.33.5422","volume":"29","author":"TI Barron","year":"2011","unstructured":"Barron TI, Connolly RM, Sharp L, Bennett K, Visvanathan K (2011) Beta blockers and breast cancer mortality: a population-based study. J Clin Oncol 29:2635\u20132644","journal-title":"J Clin Oncol"},{"key":"2521_CR37","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1200\/JCO.2010.33.4441","volume":"29","author":"A Melhem-Bertrandt","year":"2011","unstructured":"Melhem-Bertrandt A, Chavez-MacGregor M, Lei XD, Brown EN, Lee RT, Meric-Bernstam F, Sood AK, Conzen SD, Hortobagyi GN, Gonzalez-Angulo AM (2011) Beta-blocker use is associated with improved relapse-free survival in patients with triple-negative breast cancer. J Clin Oncol 29:2645\u20132652","journal-title":"J Clin Oncol"},{"key":"2521_CR38","doi-asserted-by":"crossref","first-page":"585","DOI":"10.3109\/07357907.2011.616252","volume":"29","author":"YK Chae","year":"2011","unstructured":"Chae YK, Valsecchi ME, Kim J, Bianchi AL, Khemasuwan D, Desai A, Tester W (2011) Reduced risk of breast cancer recurrence in patients using ace inhibitors, ARBs, and\/or statins. Cancer Invest 29:585\u2013593","journal-title":"Cancer Invest"},{"key":"2521_CR39","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/00005650-199601000-00006","volume":"34","author":"JN Katz","year":"1996","unstructured":"Katz JN, Chang LC, Sangha O, Fossel AH, Bates DW (1996) Can comorbidity be measured by questionnaire rather than medical record review? Med Care 34:73\u201384","journal-title":"Med Care"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-013-2521-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-013-2521-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-013-2521-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,25]],"date-time":"2020-07-25T11:24:02Z","timestamp":1595676242000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-013-2521-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,19]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["2521"],"URL":"https:\/\/doi.org\/10.1007\/s10549-013-2521-2","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,19]]}}}